Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil
- 17 May 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 49 (10) , 1419-1426
- https://doi.org/10.1016/0006-2952(95)00067-a
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Adaptation to 5‐fluorouracil of the heterogeneous human colon tumor cell line ht‐29 results in the selection of cells committed to differentiationInternational Journal of Cancer, 1991
- Relationship between 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomasBiochemical Pharmacology, 1986
- Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activitiesBiochemical Pharmacology, 1985
- Gene amplification in cultured animal cellsCell, 1984
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1984
- Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetaseBiochemical Pharmacology, 1981
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylateBiochemistry, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Nucleotide Formation as a Determinant of 5-Fluorouracil Response in Mouse LeukemiasScience, 1966